Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1997 Nov;6(11):2365–2374. doi: 10.1002/pro.5560061110

Molecular mechanics calculations on Rous sarcoma virus protease with peptide substrates.

I T Weber 1, R W Harrison 1
PMCID: PMC2143590  PMID: 9385639

Abstract

Molecular models of Rous sarcoma virus (RSV) protease and 20 peptide substrates with single amino acid substitutions at positions from P4 to P3', where the scissile bond is between P1 and P1'. were built and compared with kinetic measurements. The unsubstituted peptide substrate. Pro-Ala-Val-Ser-Leu-Ala-Met-Thr, represents the NC-PR cleavage site of RSV protease. Models were built of two intermediates in the catalytic reaction, RSV protease with peptide substrate and with the tetrahedral intermediate. The energy minimization used an algorithm that increased the speed and eliminated a cutoff for nonbonded interactions. The calculated protease-substrate interaction energies showed correlation with the relative catalytic efficiency of peptide hydrolysis. The calculated interaction energies for the 8 RSV protease-substrate models with changes in P1 to P1' next to the scissile bond gave the highest correlation coefficient of 0.79 with the kinetic measurements, whereas all 20 substrates showed the lower, but still significant correlation of 0.46. Models of the tetrahedral reaction intermediates gave a correlation of 0.72 for the 8 substrates with changes next to the scissile bond, whereas a correlation coefficient of only 0.34 was observed for all 20 substrates. The differences between the energies calculated for the tetrahedral intermediate and the bound peptide gave the most significant correlation coefficients of 0.90 for models with changes in P1 and P1', and 0.56 for all substrates. These results are compared to those from similar calculations on HIV-1 protease and discussed in relation to the rate-limiting steps in the catalytic mechanism and the entropic contributions.

Full Text

The Full Text of this article is available as a PDF (991.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron C. E., Grinde B., Jacques P., Jentoft J., Leis J., Wlodawer A., Weber I. T. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J Biol Chem. 1993 Jun 5;268(16):11711–11720. [PubMed] [Google Scholar]
  2. Cameron C. E., Grinde B., Jentoft J., Leis J., Weber I. T., Copeland T. D., Wlodawer A. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins. J Biol Chem. 1992 Nov 25;267(33):23735–23741. [PubMed] [Google Scholar]
  3. Flores T. P., Orengo C. A., Moss D. S., Thornton J. M. Comparison of conformational characteristics in structurally similar protein pairs. Protein Sci. 1993 Nov;2(11):1811–1826. doi: 10.1002/pro.5560021104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grinde B., Cameron C. E., Leis J., Weber I. T., Wlodawer A., Burstein H., Skalka A. M. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J Biol Chem. 1992 May 15;267(14):9491–9498. [PubMed] [Google Scholar]
  5. Gustchina A., Sansom C., Prevost M., Richelle J., Wodak S. Y., Wlodawer A., Weber I. T. Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures. Protein Eng. 1994 Mar;7(3):309–317. doi: 10.1093/protein/7.3.309. [DOI] [PubMed] [Google Scholar]
  6. Harrison R. W., Weber I. T. Molecular dynamics simulations of HIV-1 protease with peptide substrate. Protein Eng. 1994 Nov;7(11):1353–1363. doi: 10.1093/protein/7.11.1353. [DOI] [PubMed] [Google Scholar]
  7. Holloway M. K., Wai J. M., Halgren T. A., Fitzgerald P. M., Vacca J. P., Dorsey B. D., Levin R. B., Thompson W. J., Chen L. J., deSolms S. J. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. J Med Chem. 1995 Jan 20;38(2):305–317. doi: 10.1021/jm00002a012. [DOI] [PubMed] [Google Scholar]
  8. Hyland L. J., Tomaszek T. A., Jr, Meek T. D. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. Biochemistry. 1991 Aug 27;30(34):8454–8463. doi: 10.1021/bi00098a024. [DOI] [PubMed] [Google Scholar]
  9. Kurinov I. V., Harrison R. W. Prediction of new serine proteinase inhibitors. Nat Struct Biol. 1994 Oct;1(10):735–743. doi: 10.1038/nsb1094-735. [DOI] [PubMed] [Google Scholar]
  10. Miller M., Jaskólski M., Rao J. K., Leis J., Wlodawer A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature. 1989 Feb 9;337(6207):576–579. doi: 10.1038/337576a0. [DOI] [PubMed] [Google Scholar]
  11. Oroszlan S., Luftig R. B. Retroviral proteinases. Curr Top Microbiol Immunol. 1990;157:153–185. doi: 10.1007/978-3-642-75218-6_6. [DOI] [PubMed] [Google Scholar]
  12. Pettit S. C., Simsic J., Loeb D. D., Everitt L., Hutchison C. A., 3rd, Swanstrom R. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem. 1991 Aug 5;266(22):14539–14547. [PubMed] [Google Scholar]
  13. Polgár L., Szeltner Z., Boros I. Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease. Biochemistry. 1994 Aug 9;33(31):9351–9357. doi: 10.1021/bi00197a040. [DOI] [PubMed] [Google Scholar]
  14. Smith R., Brereton I. M., Chai R. Y., Kent S. B. Ionization states of the catalytic residues in HIV-1 protease. Nat Struct Biol. 1996 Nov;3(11):946–950. doi: 10.1038/nsb1196-946. [DOI] [PubMed] [Google Scholar]
  15. Tözsér J., Bagossi P., Weber I. T., Copeland T. D., Oroszlan S. Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases. J Biol Chem. 1996 Mar 22;271(12):6781–6788. doi: 10.1074/jbc.271.12.6781. [DOI] [PubMed] [Google Scholar]
  16. Weber I. T. Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases. J Biol Chem. 1990 Jun 25;265(18):10492–10496. [PubMed] [Google Scholar]
  17. Weber I. T., Harrison R. W. Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data. Protein Eng. 1996 Aug;9(8):679–690. doi: 10.1093/protein/9.8.679. [DOI] [PubMed] [Google Scholar]
  18. Wlodawer A., Erickson J. W. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem. 1993;62:543–585. doi: 10.1146/annurev.bi.62.070193.002551. [DOI] [PubMed] [Google Scholar]
  19. Wlodawer A., Miller M., Jaskólski M., Sathyanarayana B. K., Baldwin E., Weber I. T., Selk L. M., Clawson L., Schneider J., Kent S. B. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 1989 Aug 11;245(4918):616–621. doi: 10.1126/science.2548279. [DOI] [PubMed] [Google Scholar]
  20. Wlodawer A., Nachman J., Gilliland G. L., Gallagher W., Woodward C. Structure of form III crystals of bovine pancreatic trypsin inhibitor. J Mol Biol. 1987 Dec 5;198(3):469–480. doi: 10.1016/0022-2836(87)90294-4. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES